ImmunityBio, Inc. — Director's Dealing 2018

May 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-05-24

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-24	Common Stock	S	303	$3.96	Disposed	409600	Indirect
2018-05-25	Common Stock	S	3400	$3.97	Disposed	406200	Indirect
2018-05-25	Common Stock	S	200	$3.98	Disposed	406000	Indirect
2018-05-29	Common Stock	S	1500	$3.89	Disposed	404500	Indirect
2018-05-29	Common Stock	S	500	$3.90	Disposed	404000	Indirect
2018-05-29	Common Stock	S	100	$3.895	Disposed	403900	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	246280	Direct